RINVOQ cpr ret 30 mg 28 pce

7680672570037 CH-67257 L04AF03 07.15.0.

Reimbursement limitations:

RINVOQ.01a

Polyarthrite rhumatoïde (seulement dosage à 15 mg)
Seuls des spécialistes en rhumatologie ou des hôpitaux …

RINVOQ cpr ret 30 mg 28 pce
RINVOQ cpr ret 30 mg 28 pce
RINVOQ cpr ret 30 mg 28 pce
1 / 3
google

Details

Product number
6725705
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
upadacitinibum 30 mg ut upadacitinibum hemihydricum, cellulosum microcristallinum, hypromellosum, mannitolum, acidum tartaricum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto.

Articles (1)

Rinvoq 30 mg, Retardtabletten
Tabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/09/2025
Patient information leaflet
Français
27/09/2025
Patient information leaflet
Italien
27/09/2025
Professional SmPC
Allemand
11/09/2025
Professional SmPC
Français
11/09/2025
Professional SmPC
Italien
11/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 848.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2024

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
67257
Drug name
Rinvoq, Retardtabletten
Galenic form
RETT
ATC Code
L04AF03
Authorization status
Z
Dispensation category
B
First authorization
20/01/2020
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis (Morbus Bechterew), Atopische Dermatitis, Colitis ulcerosa, Morbus Crohn, Riesenzellarteriitis

Packaging details

Description (FR)
RINVOQ cpr ret 30 mg 28 pce
Description (DE)
RINVOQ Ret Tabl 30 mg 28 Stk
Market launch
07/06/2024
Narcotic (BTM)
No

Other packaging sizes

RINVOQ cpr ret 15 mg 28 pce
28 TABL
View
RINVOQ cpr ret 45 mg 28 pce
28 TABL
View